血液凝血障碍和缺血性中风:如何调和两者?
1Medicine Unit, Santa Maria Goretti Hospital, Via Scaravelli Snc, 04100 Latina, Italy.
Neurology international
|December 22, 2023
概括
凝血和纤维溶解系统的障碍可以导致出血和凝血,并复杂化急性神经事件. 识别双重改变是改善患者管理和治疗结果的关键.
科学领域:
- 血液学 血液学 血液学
- 神经学 神经学
- 病理生理学 病理生理学
背景情况:
- 凝血和纤维溶解系统障碍会损害血液凝固,增加血栓形成或出血的风险.
- 这些相反的倾向可以共存或相互导致,使急性脑血管事件的预后复杂化.
- 识别这些系统中的双重变化对于在具有挑战性的临床场景中减轻负面影响至关重要.
研究的目的:
- 检查凝血和纤维解的双重变化的情况.
- 为指导患有急性神经综合征的患者经历这些复杂的静血挑战的管理.
- 突出这些病态管理的未来方向.
主要方法:
- 文献综述专注于神经综合征中凝血和纤维素分解之间的相互作用.
- 对联合静血缺陷患者的临床管理策略的分析.
- 探索新兴的治疗方法和诊断方法.
主要成果:
- 凝血和纤维溶解的双重变化带来了重大管理挑战,需要在预防出血和血栓形成之间取得平衡.
- 个性化治疗是必不可少的,考虑到具体的疾病,严重程度和患者的整体状况.
- 脑卒中可能是这些静血失衡的结果,也可能是潜在病理的第一个迹象.
结论:
- 急性神经综合征的有效管理需要了解凝血和纤维素分解的双重作用.
- 精准医学,个性化治疗,先进的抗凝固和血液控制创新对于未来的治疗策略至关重要.
- 识别和解决这些复杂的静血性疾病可以改善患者的治疗结果.
相关概念视频
Disorders of Hemostasis
922
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
922
Anticoagulant Drugs: Low-Molecular-Weight Heparins
706
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
706
Introduction to Hemostasis
7.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.9K
Extrinsic and Intrinsic Pathways of Hemostasis
7.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.9K
Clot Retraction and Fibrinolysis
6.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.1K
Coagulation
6.8K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.8K


